Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Natera, Inc. (NTRA : NSDQ)
 
 • Company Description   
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

Number of Employees: 4,434

 
 • Price / Volume Information   
Yesterday's Closing Price: $161.76 Daily Weekly Monthly
20 Day Moving Average: 1,212,864 shares
Shares Outstanding: 136.55 (millions)
Market Capitalization: $22,087.84 (millions)
Beta: 1.73
52 Week High: $183.00
52 Week Low: $92.14
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.27% -7.56%
12 Week 12.90% -5.28%
Year To Date 2.19% -4.29%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
13011 McCallen Pass Building A Suite 100
-
Austin,TX 78753
USA
ph: 650-980-9190
fax: -
investor@natera.com http://www.natera.com
 
 • General Corporate Information   
Officers
Steve Chapman - Chief Executive Officer and President
Matthew Rabinowitz - Executive Chairman
Michael Brophy - Chief Financial Officer
Roy Baynes - Director
Roelof F. Botha - Director

Peer Information
Natera, Inc. (CHCR)
Natera, Inc. (ESRX)
Natera, Inc. (MYDP)
Natera, Inc. (COR)
Natera, Inc. (GBCS)
Natera, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 632307104
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 136.55
Most Recent Split Date: (:1)
Beta: 1.73
Market Capitalization: $22,087.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.51 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.10 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 17.64
Price/Cash Flow: -
Price / Sales: 12.06
EPS Growth
vs. Year Ago Period: 10.71%
vs. Previous Quarter: -21.95%
Sales Growth
vs. Year Ago Period: 36.46%
vs. Previous Quarter: 5.41%
ROE
06/30/25 - -
03/31/25 - -18.29
12/31/24 - -20.56
ROA
06/30/25 - -
03/31/25 - -11.68
12/31/24 - -12.21
Current Ratio
06/30/25 - -
03/31/25 - 3.87
12/31/24 - 4.00
Quick Ratio
06/30/25 - -
03/31/25 - 3.74
12/31/24 - 3.87
Operating Margin
06/30/25 - -
03/31/25 - -10.36
12/31/24 - -11.22
Net Margin
06/30/25 - -
03/31/25 - -10.36
12/31/24 - -11.22
Pre-Tax Margin
06/30/25 - -
03/31/25 - -10.34
12/31/24 - -11.18
Book Value
06/30/25 - -
03/31/25 - 9.17
12/31/24 - 9.05
Inventory Turnover
06/30/25 - -
03/31/25 - 15.14
12/31/24 - 15.19
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©